Bessemer Group Inc Treace Medical Concepts, Inc. Transaction History
Bessemer Group Inc
- $61.3 Billion
- Q4 2024
A detailed history of Bessemer Group Inc transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 205 shares of TMCI stock, worth $2,066. This represents 0.0% of its overall portfolio holdings.
Number of Shares
205
Previous 205
-0.0%
Holding current value
$2,066
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TMCI
# of Institutions
136Shares Held
39.4MCall Options Held
249KPut Options Held
141K-
Armistice Capital, LLC New York, NY6.21MShares$62.6 Million0.65% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$41 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.94MShares$29.6 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$27.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.14MShares$21.6 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $558M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...